De Sousa Anibal Jose Grifo Sells 14,000 Shares of Afya (NASDAQ:AFYA) Stock

Afya Limited (NASDAQ:AFYA) VP De Sousa Anibal Jose Grifo sold 14,000 shares of the company’s stock in a transaction that occurred on Monday, April 13th. The stock was sold at an average price of $15.41, for a total transaction of $215,740.00. Following the completion of the sale, the vice president directly owned 31,000 shares of the company’s stock, valued at $477,710. The trade was a 31.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

De Sousa Anibal Jose Grifo also recently made the following trade(s):

• On Tuesday, April 7th, De Sousa Anibal Jose Grifo sold 5,000 shares of Afya stock. The stock was sold at an average price of $15.20, for a total transaction of $76,000.00.

Afya Price Performance

Shares of AFYA opened at $15.50 on Thursday. The company has a 50 day moving average price of $14.51 and a 200-day moving average price of $14.67. Afya Limited has a fifty-two week low of $13.00 and a fifty-two week high of $19.90. The stock has a market capitalization of $1.45 billion, a PE ratio of 10.62, a PEG ratio of 0.69 and a beta of 0.48. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.20 and a current ratio of 2.20.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.05. Afya had a net margin of 20.31% and a return on equity of 18.77%. The firm had revenue of $147.08 million during the quarter, compared to analysts’ expectations of $174.74 million. Equities analysts predict that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Dividend Announcement

The firm also recently declared an annual dividend, which was paid on Monday, April 6th. Stockholders of record on Wednesday, March 25th were given a $0.656 dividend. This represents a dividend yield of 433.0%. The ex-dividend date of this dividend was Wednesday, March 25th. Afya’s dividend payout ratio is presently 45.21%.

Wall Street Analysts Forecast Growth

AFYA has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. Wall Street Zen raised shares of Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 14th. Bank of America cut shares of Afya from a “buy” rating to a “neutral” rating and decreased their target price for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research report on Friday, January 16th. Finally, Zacks Research raised shares of Afya from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, April 7th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $17.30.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in AFYA. Goldman Sachs Group Inc. raised its holdings in shares of Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after buying an additional 28,226 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Afya by 85.1% in the second quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock worth $931,000 after buying an additional 23,961 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Afya in the second quarter worth $117,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of Afya by 5.6% in the second quarter. Arrowstreet Capital Limited Partnership now owns 68,169 shares of the company’s stock worth $1,217,000 after buying an additional 3,626 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in shares of Afya in the second quarter worth $249,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.